Lee Scott Golden - 02 Dec 2025 Form 4 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role: Director
Signature: /s/ Matthew K. Szot, Attorney-in-fact
Issuer symbol: CVKD
Transactions as of: 02 Dec 2025
Net transactions value: $0
Form type: 4
Filing time: 03 Dec 2025, 20:08:16 UTC
Previous filing: 03 Dec 2025
Next filing: 06 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Golden Lee Scott	Director	C/O CADRENAL THERAPEUTICS, INC.,, 822 A1A NORTH, SUITE 306, PONTE VEDRA	/s/ Matthew K. Szot, Attorney-in-fact	03 Dec 2025	0001686217

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVKD	Stock Options	Award	$0	+5,000		$0.000000	5,000	02 Dec 2025	Common Stock	5,000	$8.27	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of options to purchase 5,000 shares of common stock, which shall vest 1/3 on January 1, 2027 and thereafter pro rata on a monthly basis over 24 months, subject to the Reporting Person's continued service to the Issuer through each vesting date, having an exercise price equal to the fair market value of the Issuer's common stock on the effective date of the grant.